Miguel Verbitsky

Miguel Verbitsky

Auto-generated profile, based on publicly available information

Miguel Verbitsky

Division of Nephrology, Department of Medicine, Columbia University Medical Center, New York, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2018 in Nature Genetics
Verified
Journal Article
Open access
PDF file
MVMiguel Verbitsky
Miguel Verbitsky
RWRik Westland
Rik Westland
APAlejandra Perez
Alejandra Perez
KKKrzysztof Kiryluk
Krzysztof Kiryluk
QLQingxue Liu
Qingxue Liu
SSSimone Sanna-Cherchi
Simone Sanna-Cherchi
Congenital anomalies of the kidney and urinary tract (CAKUT) are a major cause of pediatric kidney failure. We performed a genome-wide analysis of copy number variants (CNVs) in 2,824 cases and 21,498 controls. Affected individuals carried a significant burden of rare exonic (that is, affecting coding regions) CNVs and were enriched for known genomic disorders (GD). Kidney anomaly (KA) cases were most enriched for exonic CNVs, encompassing GD-CNVs and novel deletions; obstructive uropathy (OU) had a lower CNV burden and an intermediate prevalence of GD-CNVs; and vesicoureteral reflux (VUR) had the fewest GD-CNVs but was enriched for novel exonic CNVs, particularly duplications. Six loci (1q21, 4p16.1-p16.3, 16p11.2, 16p13.11, 17q12 and 22q11.2) accounted for 65% of patients with GD-CNVs. Deletions at 17q12, 4p16.1-p16.3 and 22q11.2 were specific for KA; the 16p11.2 locus showed extensive pleiotropy. Using a multidisciplinary approach, we identified TBX6 as a driver for the CAKUT subphenotypes in the 16p11.2 microdeletion syndrome.

30 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
YGYask Gupta
Yask Gupta
DFDavid J. Friedman
David J. Friedman
MMMichelle T. McNulty
Michelle T. McNulty
AKAtlas Khan
Atlas Khan
BLBrandon Lane
Brandon Lane
SSSimone Sanna-Cherchi
Simone Sanna-Cherchi
African Americans have a significantly higher risk of developing chronic kidney disease, especially focal segmental glomerulosclerosis -, than European Americans. Two coding variants (G1 and G2) in the APOL1 gene play a major role in this disparity. While 13% of African Americans carry the high-risk recessive genotypes, only a fraction of these individuals develops FSGS or kidney failure, indicating the involvement of additional disease modifiers. Here, we show that the presence of the APOL1 p.N264K missense variant, when co-inherited with the G2 APOL1 risk allele, substantially reduces the penetrance of the G1G2 and G2G2 high-risk genotypes by rendering these genotypes low-risk. These results align with prior functional evidence showing that the p.N264K variant reduces the toxicity of the APOL1 high-risk alleles. These findings have important implications for our understanding of the mechanisms of APOL1-associated nephropathy, as well as for the clinical management of individuals with high-risk genotypes that include the G2 allele.

7 August 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
HRHila Milo Rasouly
Hila Milo Rasouly
SMSarath Babu Krishna Murthy
Sarath Babu Krishna Murthy
NVNatalie Vena
Natalie Vena
GPGundula Povysil
Gundula Povysil
ABAndrew Beenken
Andrew Beenken
AGAli G. Gharavi
Ali G. Gharavi
Congenital anomalies of the kidneys and urinary tract (CAKUT) are developmental disorders that commonly cause pediatric chronic kidney disease and mortality. We examine here rare coding variants in 248 CAKUT trios and 1742 singleton CAKUT cases and compare them to 22,258 controls. Diagnostic and candidate diagnostic variants are detected in 14.1% of cases. We find a significant enrichment of rare damaging variants in constrained genes expressed during kidney development and in genes associated with other developmental disorders, suggesting phenotype expansion. Consistent with these data, 18% of CAKUT patients with diagnostic variants have neurodevelopmental or cardiac phenotypes. We identify 40 candidate genes, including CELSR1, SSBP2, XPO1, NR6A1, and ARID3A. Two are confirmed as CAKUT genes: ARID3A and NR6A1. This study suggests that many yet-unidentified syndromes would be discoverable with larger cohorts and cross-phenotype analysis, leading to clarification of the genetic and phenotypic spectrum of developmental disorders.

11 March 2025 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
FZFrancesca Zanoni
Francesca Zanoni
MMMaddalena Marasa
Maddalena Marasa
LCLucrezia Carlassara
Lucrezia Carlassara
MVMiguel Verbitsky
Miguel Verbitsky
AKAtlas Khan
Atlas Khan
KKKrzysztof Kiryluk
Krzysztof Kiryluk
Key Points: Family history of kidney disease was not associated with kidney disease progression in the context of established CKD. Family history of diabetes was a risk factor of CKD progression independently of diabetes status, polygenic risk, and traditional risk factors. Background: A family history of health conditions may reflect shared genetic and/or environmental risk. It is not well known to what extent family history affects outcomes among patients with CKD. In this study, we investigated the associations of family history of CKD, diabetes, and other conditions with common comorbidities and kidney disease progression among patients with CKD. Methods: We performed an observational study of two prospective CKD cohorts, 2573 adults and children from the Cure Glomerulopathy Network and 3939 Chronic Renal Insufficiency Cohort adult participants. Self-reported first-degree family history of CKD, diabetes, and other common diseases was tested for associations with the risk of comorbidities and CKD progression using multivariable models. Results: Family history of common comorbid conditions was associated with higher risk of these conditions in the context of CKD, including approximately by over three-fold for diabetes (adjusted odds ratio [OR], 3.37; 95% confidence interval [CI], 2.73 to 4.15), 48% for cancer (adjusted OR, 1.48; 95% CI, 1.05 to 2.09), and 69% for cardiovascular disease (adjusted OR, 1.69; 95% CI, 1.36 to 2.10 in combined cohorts). While polygenic risk score (PRS) for CKD was associated with kidney disease progression (adjusted hazards ratio, 1.11; 95% CI, 1.06 to 1.16 in combined cohorts), family history of kidney disease was not an independent risk factor of disease progression in the context of existing CKD. By contrast, family history of diabetes was significantly associated with a higher risk of CKD progression independently of diabetes occurrence or PRS for diabetes (adjusted hazards ratio, 1.19; 95% CI, 1.05 to 1.35 in combined cohorts). Conclusions: Broad collection of family history in the context of CKD improved clinical risk stratification. Family history of diabetes was consistently associated with a higher risk of CKD progression independently of diabetes status or PRS for diabetes in both cohorts.

27 February 2019 in Nature Genetics
Verified
Journal Article
Closed access
MVMiguel Verbitsky
Miguel Verbitsky
RWRik Westland
Rik Westland
APAlejandra Perez
Alejandra Perez
KKKrzysztof Kiryluk
Krzysztof Kiryluk
QLQingxue Liu
Qingxue Liu
SSSimone Sanna-Cherchi
Simone Sanna-Cherchi

14 January 2026 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
LVLisanne M. Vendrig
Lisanne M. Vendrig
JKJuntao Ke
Juntao Ke
MTMichael WT Tanck
Michael WT Tanck
TLTze Y. Lim
Tze Y. Lim
EMElena Martinelli
Elena Martinelli
RWRik Westland
Rik Westland